Similarly, research needs to be performed to examine the affinity and efficacy of widespread SCBs acting at possible mobile targets other than CBRs, which includes adrenergic, serotonergic and glutaminergic receptors. Adverse results produced by SCBs are unlikely to consequence from impurities incurred through SCB planning (Ginsburg et al., 2012).